Research ArticleClinical Studies

High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma

HIROSHI YAEGASHI, KOUJI IZUMI, SUGURU KADOMOTO, RENATO NAITO, TOMOYUKI MAKINO, HIROAKI IWAMOTO, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI
Anticancer Research January 2019, 39 (1) 375-380; DOI: https://doi.org/10.21873/anticanres.13122

Article Information

vol. 39 no. 1 375-380
DOI 
https://doi.org/10.21873/anticanres.13122
PubMed 
30591483
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 5, 2018
  • Revision received November 29, 2018
  • Accepted December 4, 2018
  • Published online December 27, 2018.
Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. HIROSHI YAEGASHI,
  2. KOUJI IZUMI⇑,
  3. SUGURU KADOMOTO,
  4. RENATO NAITO,
  5. TOMOYUKI MAKINO,
  6. HIROAKI IWAMOTO,
  7. TAKAHIRO NOHARA,
  8. KAZUYOSHI SHIGEHARA,
  9. YOSHIFUMI KADONO and
  10. ATSUSHI MIZOKAMI
  1. Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
  1. Correspondence to: Dr. Kouji Izumi, Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8640, Japan. Tel: +81 762652393, Fax: +81 762344263, e-mail: azuizu2003{at}yahoo.co.jp
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma
HIROSHI YAEGASHI, KOUJI IZUMI, SUGURU KADOMOTO, RENATO NAITO, TOMOYUKI MAKINO, HIROAKI IWAMOTO, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO, ATSUSHI MIZOKAMI
Anticancer Research Jan 2019, 39 (1) 375-380; DOI: 10.21873/anticanres.13122
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords